By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arsanis, Inc. 

16 Cavendish Court

Lebanon  New Hampshire  03766  U.S.A.
Phone: 603-727-7107 Fax: n/a



Company News
Arsanis, Inc. Initiates Phase 1 Study Of Lead Product Candidate ASN100 11/23/2015 8:20:26 AM
Arsanis, Inc. Appoints David Mantus As Executive Vice President, Regulatory Affairs, Clinical And Technical Operations 11/4/2015 7:41:48 AM
Arsanis, Inc. Appoints Rene Russo To Executive Team; Strengthens Board Of Directors With Industry Veterans Amy Schulman And Dan Burgess 8/19/2015 10:19:23 AM
Arsanis, Inc. Researchers Report Broadly Neutralizing Cross-Reactive Monoclonal Antibody Targeting Multiple Staphylococcus aureus Cytotoxins 1/15/2015 10:23:20 AM
Arsanis, Inc. Closes $20 Million Series B Financing 9/3/2013 7:53:35 AM
Arsanis, Inc. Nominates Preclinical Candidate for Staphylococcus aureus Program 5/23/2013 11:05:35 AM
Arsanis, Inc. Expands Its Anti-Infective Monoclonal Antibody Programs With Additional Grant Support From FFG and EUROSTARS 9/10/2012 9:16:14 AM
Arsanis, Inc. Announces Formation of Scientific Advisory Board 9/15/2011 10:29:08 AM
Arsanis, Inc. Inks $10M Series A 2/28/2011 7:33:01 AM
Secretive Biotech Arsanis, Inc. Raises $9.6M 2/9/2011 8:30:24 AM